SUBSCRIBE

FDA delays meeting to evaluate infliximab biosimilar

 posted 27/02/2015

The US Food and Drug Administration (FDA) has postponed a meeting of its Arthritis Advisory Committee, which was to discuss an infliximab biosimilar.

more
Biosimilars of rituximab Biosimilars/General | Posted 27/02/2015
Pfizer warns UK doctors not to prescribe generi... Generics/General | Posted 27/02/2015
Canada clamps down on companies failing to post... Pharma News | Posted 27/02/2015
FDA re-opens comment period on generics labelli... Policies & Legislation | Posted 27/02/2015
Accord launches biosimilar filgrastim in Europe Biosimilars/News | Posted 27/02/2015
Actavis receives generic opioid approval and pl... Generics/News | Posted 27/02/2015
Brazil looks to follow-on biological products t... Reports | Posted 27/02/2015
World Biosimilar Congress USA 2015 Conferences | Posted 27/02/2015
Generics and off-patent biologicals for cancer... Biosimilars/Research | Posted 20/02/2015
Substitution and adherence to antidiabetic gene... Generics/Research | Posted 20/02/2015
Positive phase III data for Amgen adalimumab bi... Biosimilars/Research | Posted 20/02/2015
Pfizer sets to lead biosimilars and generics ma... Pharma News | Posted 20/02/2015
FDA calls for comment on generics user fees gui... Guidelines | Posted 20/02/2015
Generics gaining ground in French pharmaceutica... Reports | Posted 20/02/2015
Hospira and Pfenex to collaborate on ranibizuma... Biosimilars/News | Posted 20/02/2015
Mylan being sued over sorafenib generic Generics/News | Posted 20/02/2015
Biosimilars compared to generics in the Europea... Biosimilars/Research | Posted 13/02/2015
FDA advisers to consider infliximab biosimilar Biosimilars/News | Posted 13/02/2015
EMA explains redaction of AbbVie’s data Policies & Legislation | Posted 13/02/2015
Biosimilars of infliximab Biosimilars/General | Posted 13/02/2015
Mylan on track to acquire Abbott generics and e... Pharma News | Posted 13/02/2015
Dr Reddy’s could move manufacturing site with v... Generics/News | Posted 13/02/2015
Torrent licenses three ‘similar biologics’ from... Biosimilars/News | Posted 13/02/2015
US pay-for-delay deals decrease in 2013 Reports | Posted 13/02/2015
FDA calls for comment on biosimilars interchang... Guidelines | Posted 06/02/2015
Generics versus brand-name drugs Generics/Research | Posted 06/02/2015
Impact of nephrology subsequent entry biologics... Biosimilars/Research | Posted 06/02/2015
Hanwha to transfer biosimilar etanercept techno... Biosimilars/News | Posted 06/02/2015
EMA recommends suspending generics from GVK Bio Policies & Legislation | Posted 06/02/2015
Actavis to buy UK generics maker Auden McKenzie Pharma News | Posted 06/02/2015
Generics still cost more in Canada, but prices... Reports | Posted 06/02/2015
Akorn submits ANDA for difluprednate ophthalmic... Generics/News | Posted 06/02/2015
Irish doctors’ attitudes towards generics Generics/Research | Posted 30/01/2015
Japanese approval for insulin glargine biosimilar Biosimilars/News | Posted 30/01/2015
No relevant difference in ADRs from biosimilars... Biosimilars/Research | Posted 30/01/2015
EMA to collaborate with other agencies on generics Policies & Legislation | Posted 30/01/2015
Biosimilars applications under review by EMA –... Biosimilars/General | Posted 30/01/2015
FDA approves first generic esomeprazole Generics/News | Posted 30/01/2015
FDA releases 53 new and revised bioequivalence... Guidelines | Posted 30/01/2015
Adalimumab similar biologic launched in India Biosimilars/News | Posted 30/01/2015
11th EGA Legal Affairs Forum Conferences | Posted 30/01/2015
Australia reviewing plans for naming biosimilars Guidelines | Posted 23/01/2015
Biosimilar etanercept submitted for approval in EU Biosimilars/News | Posted 23/01/2015
Generics applications under review by EMA – Dec... Generics/General | Posted 23/01/2015
Filgrastim biosimilar has similar safety and ef... Biosimilars/Research | Posted 23/01/2015
Amgen’s approach in the biosimilars market Pharma News | Posted 23/01/2015
Prasco to market authorized colchicine generic... Generics/News | Posted 23/01/2015
UK outlines process for developing biosimilars... Policies & Legislation | Posted 23/01/2015
Mabion starts phase III trial for rituximab bio... Biosimilars/News | Posted 23/01/2015
more

Country Focus

All countries

Sign up today to receive weekly news on the latest developments in generic and biosimilar medicines!

Generics News Research General

more

Biosimilars News Research General

more

More editorial sections